MaxCyte, Inc.
MXCT
$1.52
-$0.05-3.19%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -24.52% | -21.32% | -14.48% | -6.44% | 19.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -24.52% | -21.32% | -14.48% | -6.44% | 19.85% |
| Cost of Revenue | 7.84% | 37.44% | 39.83% | 49.73% | 35.56% |
| Gross Profit | -29.79% | -29.00% | -21.66% | -13.73% | 17.63% |
| SG&A Expenses | -10.74% | -3.72% | -2.78% | -1.21% | 9.80% |
| Depreciation & Amortization | 0.45% | -0.38% | -0.12% | 3.96% | 10.28% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.67% | -2.73% | -2.80% | 0.27% | 8.23% |
| Operating Income | -8.89% | -15.52% | -8.06% | -6.00% | 1.20% |
| Income Before Tax | -27.69% | -26.37% | -14.28% | -8.26% | 4.59% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -27.69% | -26.37% | -14.28% | -8.26% | 4.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.69% | -26.37% | -14.28% | -8.26% | 4.59% |
| EBIT | -8.89% | -15.52% | -8.06% | -6.00% | 1.20% |
| EBITDA | -9.89% | -17.28% | -8.92% | -6.24% | 2.17% |
| EPS Basic | -25.67% | -24.21% | -12.34% | -6.53% | 5.97% |
| Normalized Basic EPS | -17.36% | -24.23% | -12.37% | -6.58% | 5.94% |
| EPS Diluted | -25.67% | -24.21% | -12.34% | -6.53% | 5.97% |
| Normalized Diluted EPS | -17.36% | -24.23% | -12.37% | -6.58% | 5.94% |
| Average Basic Shares Outstanding | 1.67% | 1.71% | 1.68% | 1.53% | 1.47% |
| Average Diluted Shares Outstanding | 1.67% | 1.71% | 1.68% | 1.53% | 1.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |